Ayala Financial Statements From 2010 to 2024
| ADXSDelisted Stock | USD 0.62 0.03 4.62% |
Check Ayala Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ayala main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Ayala financial statements analysis is a perfect complement when working with Ayala Pharmaceuticals Valuation or Volatility modules.
Ayala |
Ayala Pharmaceuticals OTC Stock Shares Owned By Insiders Analysis
Ayala Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Ayala Pharmaceuticals Shares Owned By Insiders | 0.01 % |
Most of Ayala Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ayala Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 0.01% of Ayala Pharmaceuticals are shares owned by insiders. This is 99.93% lower than that of the Healthcare sector and 99.93% lower than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 99.9% higher than that of the company.
Ayala Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ayala Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Ayala Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ayala Pharmaceuticals competition to find correlations between indicators driving Ayala Pharmaceuticals's intrinsic value. More Info.Ayala Pharmaceuticals is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ayala Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ayala Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ayala Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Ayala Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ayala Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ayala Pharmaceuticals investors use historical funamental indicators, such as Ayala Pharmaceuticals's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ayala Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ayala Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ayala Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ayala Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ayala Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ayala Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ayala Pharmaceuticals' short interest history, or implied volatility extrapolated from Ayala Pharmaceuticals options trading.
Pair Trading with Ayala Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ayala Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Ayala OTC Stock
| 0.74 | ELOX | Eloxx Pharmaceuticals | PairCorr |
| 0.63 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.78 | ENZN | Enzon Pharmaceuticals | PairCorr |
| 0.84 | EVFM | Evofem Biosciences | PairCorr |
Moving against Ayala OTC Stock
| 0.67 | ENGN | enGene Holdings Common | PairCorr |
| 0.67 | BAYRY | Bayer AG PK | PairCorr |
| 0.52 | NGM | NGM Biopharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Ayala Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ayala Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ayala Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ayala Pharmaceuticals to buy it.
The correlation of Ayala Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ayala Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ayala Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ayala Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |